Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eulalie Courcelles"'
Autor:
Flora T. Musuamba, Ine Skottheim Rusten, Raphaëlle Lesage, Giulia Russo, Roberta Bursi, Luca Emili, Gaby Wangorsch, Efthymios Manolis, Kristin E. Karlsson, Alexander Kulesza, Eulalie Courcelles, Jean‐Pierre Boissel, Cécile F. Rousseau, Emmanuelle M. Voisin, Rossana Alessandrello, Nuno Curado, Enrico Dall’ara, Blanca Rodriguez, Francesco Pappalardo, Liesbet Geris
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 804-825 (2021)
Abstract The value of in silico methods in drug development and evaluation has been demonstrated repeatedly and convincingly. While their benefits are now unanimously recognized, international standards for their evaluation, accepted by all stakehold
Externí odkaz:
https://doaj.org/article/97e2e67f5a5b4314bf9e9f73a5497dde
Autor:
Eulalie Courcelles, Jean-Pierre Boissel, Jacques Massol, Ingrid Klingmann, Riad Kahoul, Marc Hommel, Emmanuel Pham, Alexander Kulesza
Publikováno v:
Frontiers in Medical Technology, Vol 4 (2022)
Health technology assessment (HTA) aims to be a systematic, transparent, unbiased synthesis of clinical efficacy, safety, and value of medical products (MPs) to help policymakers, payers, clinicians, and industry to make informed decisions. The evide
Externí odkaz:
https://doaj.org/article/1e7b009820134255918cde935affaa5d
Autor:
Flora T. Musuamba, Roberta Bursi, Efthymios Manolis, Kristin Karlsson, Alexander Kulesza, Eulalie Courcelles, Jean‐Pierre Boissel, Raphaëlle Lesage, Cécile Crozatier, Emmanuelle M. Voisin, Cécile F. Rousseau, Thierry Marchal, Rossana Alessandrello, Liesbet Geris
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 4, Pp 195-197 (2020)
Externí odkaz:
https://doaj.org/article/8e304d8ae5af4f9299edf6995437c78f
Autor:
Cécile F. Rousseau, Kristin E. Karlsson, Raphaëlle Lesage, Eulalie Courcelles, Emmanuelle M. Voisin, Francesco Pappalardo, Nuno Curado, Enrico Dall'Ara, Flora T. Musuamba, Gaby Wangorsch, Blanca Rodriguez, Ine Skottheim Rusten, Rossana Alessandrello, Roberta Bursi, Giulia Russo, Luca Emili, Efthymios Manolis, Jean-Pierre Boissel, Liesbet Geris, Alexander Kulesza
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 8, Pp 804-825 (2021)
CPT: pharmacometrics & systems pharmacology, 10(8):804-825
CPT: Pharmacometrics & Systems Pharmacology
CPT: pharmacometrics & systems pharmacology, 10(8):804-825
CPT: Pharmacometrics & Systems Pharmacology
The value of in silico methods in drug development and evaluation has been demonstrated repeatedly and convincingly. While their benefits are now unanimously recognized, international standards for their evaluation, accepted by all stakeholders invol
Autor:
Cécile F. Rousseau, Axel Loewe, Marc Horner, Nele Famaey, Michael Neidlin, Francesco Pappalardo, Marco Viceconti, Luca Emili, Emmanuelle M. Voisin, Payman Afshari, Markus Reiterer, Eulalie Courcelles, Simon J. Sonntag, Cristina Curreli, Maria Cristina Jori, Giulia Russo, Liesbet Geris, Alexander Kulesza
Publikováno v:
IEEE Journal of Biomedical and Health Informatics, 25 (10), 3977-3982
The term "In Silico Trial" indicates the use of computer modelling and simulation to evaluate the safety and efficacy of a medical product, whether a drug, a medical device, a diagnostic product or an advanced therapy medicinal product. Predictive mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8ac52a314fdb3e8091a3550701435b6
http://hdl.handle.net/11585/855726
http://hdl.handle.net/11585/855726
Autor:
Raphaëlle Lesage, Flora T. Musuamba, Thierry Marchal, Cécile Crozatier, Jean-Pierre Boissel, Efthymios Manolis, Eulalie Courcelles, Liesbet Geris, Cécile F. Rousseau, Kristin E. Karlsson, Alexander Kulesza, Rossana Alessandrello, Roberta Bursi, Emmanuelle M. Voisin
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 4, Pp 195-197 (2020)
CPT: Pharmacometrics & Systems Pharmacology, Vol 9, Iss 4, Pp 195-197 (2020)
The added value of in silico models (including quantitative systems pharmacology models) for drug development is now unanimously recognized. It is, therefore, important that the standards used are commonly acknowledged by all the parties involved. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f6e77d14a3d5b9285f9715027488f5
https://lirias.kuleuven.be/handle/123456789/652695
https://lirias.kuleuven.be/handle/123456789/652695